Proton Therapy Publication
Proton therapy publication
July 2019
A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiotherapy for Esophageal Cancer.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
July 2019
Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
June 2019
Four-year outcomes from a prospective phase II clinical trial of moderately hypofractionated PT for localized prostate cancer.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
May 2019
Proton Radiotherapy for Isolated Local Recurrence of Primary Resected Pancreatic Ductal Adenocarcinoma.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
April 2019
Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
March 2019
Early and late side effects, dosimetric parameters and QoL after PBT and IMRT for prostate cancer
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
February 2019
Patient-Reported Sexual Survivorship Following High-Dose Image-Guided PT for Prostate Cancer.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
January 2019
Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
September 2018
Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
August 2018
Proton theraphy for adults with mediastinal lymphomas: The international lymphoma radiation oncology group (ILROG) guidelines.
Link to the fully detailed content